References
- Ghoncheh M, Pournamdar Z, Salehiniya H. Incidence and mortality and epidemiology of breast cancer in the world. Asian Pac J Cancer Prev. 2016; 17:43–6.
- Hefti MM, Hu R, Knoblauch NW, Collins LC, Haibe-Kains B, Tamimi RM, Beck AH. Estrogen receptor negative/progesterone receptor positive breast cancer is not a reproducible subtype. Breast Cancer Res. 2013; 15:R68. doi: 10.1186/bcr3462
- Standish JL, Sweet SE, Novack J, Wenner AC, Bridge C, Nelson A, et al. Breast cancer and the immune system. J Soc Integr Oncol. 2008; 6:158–68.
- Stewart AD, Yang Y, Makowski L, Troester MA. Basal-like breast cancer cells induce phenotypic and genomic changes in macrophages. Mol Cancer Res. 2012; 10:727–38.
- Sasser AK, Sullivan NJ, Studebaker AW, Hendey LF, Axel AE, Hall BM. Interleukin-6 is a potent growth factor for ER-α-positive human breast cancer. FASEB J. 2007; 21:3763–70.
- Todorović-Raković N, Milovanović J. Interleukin-8 in breast cancer progression. J Interferon Cytokine Res. 2013; 33:563–70.
- Kozłowski L, Zakrzewska I, Tokajuk P, Wojtukiewicz MZ. Concentration of interleukin-6 (IL-6), interleukin-8 (IL-8) and interleukin-10 (IL-10) in blood serum of breast cancer patients. Rocz Akad Med Bia1ymst. 2003; 48:82–4.
- Nicolini A, Carpi A, Rossi G. Cytokines in breast cancer. Cytokine Growth Factor Rev. 2006; 17:325–37.
- Hamed EA, Zakhary MM, Maximous DW. Apoptosis, angiogenesis, inflammation, and oxidative stress: basic interactions in patients with early and metastatic breast cancer. J Cancer Res Clin Oncol. 2012; 138:999–1009.
- Ashbury JE, Lévesque LE, Beck PA, Aronson KJ. Selective serotonin reuptake inhibitor (SSRI) antidepressants, prolactin and breast cancer. Front Oncol. 2012; 2:117. doi: 10.3389/fonc.2012.00177
- Vashistha VK, Sethi S, Tyagi I, Das DK. Chirality of antidepressive drugs: an overview of stereoselectivity. Asian Biomed (Res Rev News). 2022; 16:55–69.
- Sarrouilhe D, Mesnil M. Serotonin and human cancer: a critical view. Biochimie. 2019; 161:46–50.
- Kanarya Vardar M, Tezcan B, Belli H, Öztürk HN, Adalı Aker D. Essitalopram kullanımı sonrasında doza bağlı gelişen spontan ekimotik lezyonlar: olgu sunumu. Anadolu Psikiyatri Dergisi. 2017; 18:503–6.
- Hedges WD, Woon FL. An emerging role for escitalopram in the treatment of obsessive-compulsive disorder. Neuropsychiatr Dis Treat. 2007; 3:455–61.
- Canan F, Ataoglu A. Effect of escitalopram on white blood cells in patients with major depression. J Clin Med Res. 2009; 1:290–1.
- Colozza M, Califano R, Minenza E, Dinh P, Azambuja E. Aromatase inhibitors: a new reality for the adjuvant endocrine treatment of early-stage breast cancer in postmenopausal women. Mini Rev Med Chem. 2008; 8:564–74.
- Gradishar WJ. Taxanes for the treatment of metastatic breast cancer. Breast Cancer (Auckl). 2012; 6:159–71.
- Osborne CK. Tamoxifen in the treatment of breast cancer. N Eng J Med. 1998; 339:1609–18.
- Lian Z, Niwa K, Gao J, Tagami K, Mori H, Tamaya T. Association of cellular apoptosis with anti-tumor effects of the Chinese herbal complex in endocrine-resistant cancer cell line. Cancer Detect Prev. 2003; 27:147–54.
- Limame R, Wouters A, Pauwels B, Fransen E, Peeters M, Lardon F, et al. Comparative analysis of dynamic cell viability, migration and invasion assessments by novel real-time technology and classic endpoint assays. PloS One. 2012; 7:e46536. doi: 10.1371/journal.pone.0046536
- Dikmen M, Cantürk Z, Öztürk Y. Escitalopram oxalate, a selective serotonin reuptake inhibitor, exhibits cytotoxic and apoptotic effects in glioma C6 cells. Acta Neuropsychiatr. 2011; 23:173–8.
- Chanput W, Mes JJ, Savelkoul HF, Wichers HJ. Characterization of polarized THP-1 macrophages and polarizing ability of LPS and food compounds. Food Func. 2013; 4:266–76.
- Sueki A, Matsuda K, Iwashita C, Taira C, Ishimine N, Shigeto S, et al. Epithelial-mesenchymal transition of A549 cells is enhanced by co-cultured with THP-1 macrophages under hypoxic conditions. Biochem Biophys Res Commun. 2014; 453:804–9.
- Xu Z, Zheng X, Xia X, Wang X, Luo N, Huang B, Pan X. 17β-estradiol at low concentrations attenuates the efficacy of tamoxifen in breast cancer therapy. Environ Pollut. 2019; 225:113228. doi: 10.1016/j.envpol.2019.113228
- Yetkin D, Ballı E, Bayrak G, Kibar D, Şengül TM. The investigation of the effects of tamoxifen and vitamin D combination on the expression of P53, Bcl-2 and bax and cell cycle in MCF-7 cell line. Proceedings. 2018; 2:1527. doi: 10.3390/proceedings2251527
- Cansaran-Duman D, Tanman Ü, Yangın S, Atakol O. The comparison of miRNAs that respond to anti-breast cancer drugs and usnic acid for the treatment of breast cancer. Cytotechnology. 2020; 72:855–72.
- Arunasree KM. Anti-proliferative effects of carvacrol on a human metastatic breast cancer cell line, MDA-MB-231. Phytomedicine. 2010; 17:581–8.
- Mutee AF, Salhimi SM, Ghazali FC, Al-Hassan FM, Lim CP, Ibrahim K, Asmawi MZ. Apoptosis induced in human breast cancer cell line by Acanthaster planci starfish extract compared to tamoxifen. J Pharm Pharmacol. 2012; 6:129–34.
- Yaacob NS, Kamal NN, Norazmi MN. Synergistic anticancer effects of a bioactive subfraction of Strobilanthes crispus and tamoxifen on MCF-7 and MDA-MB-231 human breast cancer cell lines. BMC Complement Altern Med. 2014; 14:252. doi: 10.1186/1472-6882-14-252
- Chanput W, Mes J, Vreeburg RA, Savelkoul HF, Wichers HJ. Transcription profiles of LPS-stimulated THP-1 monocytes and macrophages: a tool to study inflammation modulating effects of food-derived compounds. Food Funct. 2010; 1:254–61.
- Ortiz-Montero P, Londono-Vallejo A, Vernot JP. Senescence-associated IL-6 and IL-8 cytokines induce a self- and cross-reinforced senescence/inflammatory milieu strengthening tumorigenic capabilities in the MCF-7 breast cancer cell line. Cell Commun Signal. 2017; 15:17. doi: 10.1186/s12964-017-0172-3
- Chen K, Satlof L, Stoffels G, Kothapalli U, Ziluck N, Lema M, et al. Cytokine secretion in breast cancer cells - MILLIPLEX assay data. Data Brief. 2019; 28:104798. doi: 10.1016/j.dib.2019.104798
- Hamidullah, Changkija B, Konwar R. Role of interleukin-10 in breast cancer. Breast Cancer Res Treat. 2012; 133:11–21.
- Edwardson DW, Boudreau J, Mapletoft J, Lanner C, Kovala AT, Parissenti AM. Inflammatory cytokine production in tumor cells upon chemotherapy drug exposure or upon selection for drug resistance. PLoS One. 2017; 12:e0183662.